TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
| Market size in 2024 | US$ 3.45 billion |
Forecast Market size by 2030 | US$ 5.12 billion |
|---|---|---|---|
| Growth Rate | CAGR of 6.8% | Number of Pages | NA Pages |
United States Implantable Drug-Eluting Devices market was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 5.12 billion by 2030, at a CAGR of 6.8% during the forecast period 2024-2030.
Medical devices designed to be implanted in the body and release drugs over time. Include drug-eluting stents, implants, and other devices that combine structural support with localized drug delivery for treating various medical conditions.
This report contains market size and forecasts of Implantable Drug-Eluting Devices in United States, including the following market information:
• United States Implantable Drug-Eluting Devices Market Revenue, 2019-2024, 2024-2030, ($ millions)
• United States Implantable Drug-Eluting Devices Market Sales, 2019-2024, 2024-2030,
• United States Top five Implantable Drug-Eluting Devices companies in 2023 (%)
Report Includes
This report presents an overview of United States market for Implantable Drug-Eluting Devices , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report focuses on the Implantable Drug-Eluting Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the United States Implantable Drug-Eluting Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.
This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.
• Diabetes
• Contraception
• HIV/AIDS Prevention
• Chronic Pain Management
• Cardiovascular
• Ophthalmology
• Oncology
• Others
• Implantable Drug Infusion Pumps
• Intraocular Drug-Eluting Devices
• Contraceptive Drug-Eluting Devices
• Drug-Eluting Stents
• Others
Key Companies covered in this report:
• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Becton, Dickinson and Company
• Merit Medical Systems
• Johnson & Johnson
• Integra LifeSciences
• Teleflex Incorporated
• West Pharmaceutical Services, Inc.
• C.R. Bard (acquired by Becton, Dickinson and Company)
Fill out the download sample Report form to access the complete list of key players.
The report also provides analysis of leading market participants including:
• Key companies Implantable Drug-Eluting Devices revenues in United Statesn market, 2019-2024 (Estimated), ($ millions)
• Key companies Implantable Drug-Eluting Devices revenues share in United Statesn market, 2023 (%)
• Key companies Implantable Drug-Eluting Devices sales in United Statesn market, 2019-2024 (Estimated),
• Key companies Implantable Drug-Eluting Devices sales share in United Statesn market, 2023 (%)
Key Indicators Analysed
• Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2030 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
• United Statesn Market Analysis: The report includes United Statesn market status and outlook 2019-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
• Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
• Opportunities and Drivers: Identifying the Growing Demands and New Technology
• Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Implantable Drug-Eluting Devices Market
• Overview of the regional outlook of the Implantable Drug-Eluting Devices Market
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
We offer additional regional and global reports that are similar:
• Global Implantable Drug-Eluting Devices Market
• United States Implantable Drug-Eluting Devices Market
• Japan Implantable Drug-Eluting Devices Market
• Germany Implantable Drug-Eluting Devices Market
• South Korea Implantable Drug-Eluting Devices Market
• Indonesia Implantable Drug-Eluting Devices Market
• Brazil Implantable Drug-Eluting Devices Market
Customization of the Report: In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.
| Report Attributes | Report Details |
|---|---|
| Report Title | United States Implantable Drug-Eluting Devices Market, Outlook and Forecast 2024-2030 |
| Market size in 2024 | US$ 3.45 billion |
| Forecast Market size by 2030 | US$ 5.12 billion |
| Growth Rate | CAGR of 6.8% |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2023 |
| Forecast Year | 2031 |
| Number of Pages | NA Pages |
| Customization Available | Yes, the report can be customized as per your need. |
1.1 Implantable Drug-Eluting Devices Product Introduction
1.2.1 United Statesn Implantable Drug-Eluting Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diabetes
1.2.3 Contraception
1.2.4 HIV/AIDS Prevention
1.2.5 Chronic Pain Management
1.2.6 Cardiovascular
1.2.7 Ophthalmology
1.2.8 Oncology
1.2.9 Others
1.3.1 United States Implantable Drug-Eluting Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Implantable Drug Infusion Pumps
1.3.3 Intraocular Drug-Eluting Devices
1.3.4 Contraceptive Drug-Eluting Devices
1.3.5 Drug-Eluting Stents
1.3.6 Others
1.4 United States Implantable Drug-Eluting Devices Sales Estimates and Forecasts 2019-2030
1.5 United States Implantable Drug-Eluting Devices Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 United States Implantable Drug-Eluting Devices Sales by Manufacturers
2.1.1 United States Implantable Drug-Eluting Devices Sales by Manufacturers (2019-2024)
2.1.2 United States Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of Implantable Drug-Eluting Devices in 2023 in United States
2.2 United States Implantable Drug-Eluting Devices Revenue by Manufacturers
2.2.1 United States Implantable Drug-Eluting Devices Revenue by Manufacturers (2019-2024)
2.2.2 United States Implantable Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
2.2.3 United States Top Companies by Implantable Drug-Eluting Devices Revenue in 2023
2.3 United States Implantable Drug-Eluting Devices Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 United States Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Implantable Drug-Eluting Devices Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 Implantable Drug-Eluting Devices Market Size by Region: 2019-2030
3.1.1 United States Implantable Drug-Eluting Devices Sales by Region: 2019-2024
3.1.2 United States Implantable Drug-Eluting Devices Sales Forecast by Region (2025-2030)
3.1.3 United States Implantable Drug-Eluting Devices Revenue by Region: 2019-2024
3.1.4 United States Implantable Drug-Eluting Devices Revenue Forecast by Region (2025-2030)
4.1 United States Implantable Drug-Eluting Devices Sales by Type
4.1.1 United States Implantable Drug-Eluting Devices Historical Sales by Type (2019-2024)
4.1.2 United States Implantable Drug-Eluting Devices Forecasted Sales by Type (2025-2030)
4.1.3 United States Implantable Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 United States Implantable Drug-Eluting Devices Revenue by Type
4.2.1 United States Implantable Drug-Eluting Devices Historical Revenue by Type (2019-2024)
4.2.2 United States Implantable Drug-Eluting Devices Forecasted Revenue by Type (2025-2030)
4.2.3 United States Implantable Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 United States Implantable Drug-Eluting Devices Price by Type
4.3.1 United States Implantable Drug-Eluting Devices Price by Type (2019-2024)
4.3.2 United States Implantable Drug-Eluting Devices Price Forecast by Type (2025-2030)
5.1 United States Implantable Drug-Eluting Devices Sales by Application
5.1.1 United States Implantable Drug-Eluting Devices Historical Sales by Application (2019-2024)
5.1.2 United States Implantable Drug-Eluting Devices Forecasted Sales by Application (2025-2030)
5.1.3 United States Implantable Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 United States Implantable Drug-Eluting Devices Revenue by Application
5.2.1 United States Implantable Drug-Eluting Devices Historical Revenue by Application (2019-2024)
5.2.2 United States Implantable Drug-Eluting Devices Forecasted Revenue by Application (2025-2030)
5.2.3 United States Implantable Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 United States Implantable Drug-Eluting Devices Price by Application
5.3.1 United States Implantable Drug-Eluting Devices Price by Application (2019-2024)
5.3.2 United States Implantable Drug-Eluting Devices Price Forecast by Application (2025-2030)
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Overview
6.1.3 Medtronic in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Drug-Eluting Devices Product Introduction
6.1.5 Medtronic Recent Developments
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Overview
6.2.3 Boston Scientific Corporation in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Introduction
6.2.5 Boston Scientific Corporation Recent Developments
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Overview
6.3.3 Abbott Laboratories in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Implantable Drug-Eluting Devices Product Introduction
6.3.5 Abbott Laboratories Recent Developments
6.4 Becton, Dickinson and Company
6.4.1 Becton, Dickinson and Company Corporation Information
6.4.2 Becton, Dickinson and Company Overview
6.4.3 Becton, Dickinson and Company in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.4.4 Becton, Dickinson and Company Implantable Drug-Eluting Devices Product Introduction
6.4.5 Becton, Dickinson and Company Recent Developments
6.5 Merit Medical Systems
6.5.1 Merit Medical Systems Corporation Information
6.5.2 Merit Medical Systems Overview
6.5.3 Merit Medical Systems in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.5.4 Merit Medical Systems Implantable Drug-Eluting Devices Product Introduction
6.5.5 Merit Medical Systems Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Overview
6.6.3 Johnson & Johnson in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Implantable Drug-Eluting Devices Product Introduction
6.6.5 Johnson & Johnson Recent Developments
6.7 Integra LifeSciences
6.7.1 Integra LifeSciences Corporation Information
6.7.2 Integra LifeSciences Overview
6.7.3 Integra LifeSciences in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.7.4 Integra LifeSciences Implantable Drug-Eluting Devices Product Introduction
6.7.5 Integra LifeSciences Recent Developments
6.8 Teleflex Incorporated
6.8.1 Teleflex Incorporated Corporation Information
6.8.2 Teleflex Incorporated Overview
6.8.3 Teleflex Incorporated in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.8.4 Teleflex Incorporated Implantable Drug-Eluting Devices Product Introduction
6.8.5 Teleflex Incorporated Recent Developments
6.9 West Pharmaceutical Services, Inc.
6.9.1 West Pharmaceutical Services, Inc. Corporation Information
6.9.2 West Pharmaceutical Services, Inc. Overview
6.9.3 West Pharmaceutical Services, Inc. in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.9.4West Pharmaceutical Services, Inc. Implantable Drug-Eluting Devices Product Introduction
6.9.5 West Pharmaceutical Services, Inc. Recent Developments
6.10 C.R. Bard (acquired by Becton, Dickinson and Company)
6.10.1 C.R. Bard (acquired by Becton, Dickinson and Company) Corporation Information
6.10.2 C.R. Bard (acquired by Becton, Dickinson and Company) Overview
6.10.3 C.R. Bard (acquired by Becton, Dickinson and Company) in United States: Implantable Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
6.10.4 C.R. Bard (acquired by Becton, Dickinson and Company) Implantable Drug-Eluting Devices Product Introduction
6.10.5 C.R. Bard (acquired by Becton, Dickinson and Company) Recent Developments
7.1 Implantable Drug-Eluting Devices Industry Chain Analysis
7.2 Implantable Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Drug-Eluting Devices Production Mode & Process
7.4 Implantable Drug-Eluting Devices Sales and Marketing
7.4.1 Implantable Drug-Eluting Devices Sales Channels
7.4.2 Implantable Drug-Eluting Devices Distributors
7.5 Implantable Drug-Eluting Devices Customers
8.1.1 Implantable Drug-Eluting Devices Industry Trends
8.1.2 Implantable Drug-Eluting Devices Market Drivers
8.1.3 Implantable Drug-Eluting Devices Market Challenges
8.1.4 Implantable Drug-Eluting Devices Market Restraints
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Frequently Asked Questions ?
